Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I
- 1 September 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 2 (9), 1573-1580
- https://doi.org/10.1111/j.1538-7836.2004.00890.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studiesThrombosis Research, 2002
- Inhibition of Thrombin Generation by the Oral Direct Thrombin Inhibitor Ximelagatran in Shed Blood from Healthy Male SubjectsThrombosis and Haemostasis, 2002
- A Dose-ranging Study of the Oral Direct Thrombin Inhibitor, Ximelagatran, and Its Subcutaneous Form, Melagatran, Compared with Dalteparin in the Prophylaxis of Thromboembolism after Hip or Knee Replacement: METHRO IThrombosis and Haemostasis, 2002
- Elevation of Hepatic Transaminases after Enoxaparin Use: Case Report and Review of Unfractionated and Low-Molecular-Weight Heparin-Induced HepatotoxicityPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
- Prevention of Venous ThromboembolismChest, 2001
- Optimization of ascending phlebography of the leg for screening of deep vein thrombosis in thromboprophylactic trialsActa Radiologica, 1997
- Bleeding Classification in Clinical Trials: Observer Variability and Clinical RelevanceThrombosis and Haemostasis, 1997
- Percentage of Inadequate Phlebograms and Observer Agreement in Thromboprophylactic Multicenter Trials Using Standardized Methodology and Central AssessmentThrombosis and Haemostasis, 1996
- Phlebographic Findings in Venous Thrombosis following Total Hip ReplacementActa Radiologica, 1990
- Phlebographic findings in venous thrombosis following total hip replacementActa Radiologica, 1990